Press Releases

August 29, 2017

Ferring Pharmaceuticals to Donate $25,000 to Hurricane Harvey Relief

Ferring Pharmaceuticals announced today that it will donate $25,000 to help the people and communities impacted by Hurricane Harvey. Ferring will make its donation to the American Red Cross, which has mobilized its resources to respond to the devastation in Texas and across the Gulf Coast region. (more)

June 01, 2017

Paul Navarre Joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.

Ferring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of Ferring Holding Inc. In this role Mr. Navarre assumes direct responsibility for all Ferring US activities including commercial operations, clinical development and manufacturing. He succeeds Aaron Graff, who has been appointed to a global role as Executive Vice President, Chief Commercial Officer and member of the Ferring Group Executive Board. (more)

June 01, 2017

Ferring appoints Aaron Graff to Executive Board

Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer and made a member of the Ferring Group Executive Board, effective immediately. (more)

April 24, 2017

Ferring Pharmaceuticals Launches Two New Resources to Help Women Struggling with Infertility during National Infertility Awareness Week®

PARSIPPANY, NJ (April 24, 2017) – Infertility is no longer something that people feel they must discuss behind closed doors. Gone are the days of hushed voices and cover stories; now, hardly a day goes by without another celebrity couple sharing that they have frozen their eggs, are undergoing fertility treatment, or are struggling to conceive. (more)

view our full press archives
This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, EUFLEXXA, FIRMAGON, and PREPOPIK are registered trademarks of Ferring B.V. ZOMACTON is a trademark of Ferring B.V.

©2008-2015 Ferring Pharmaceuticals.  GC/1722/2014/US(4)